Tissue microarrays: Applications in study of p16 and p53 alterations in Ewing's cell lines

Diagnostic Pathology

Volumn 3, Issue SUPPL.1, 2008, Pages

  Noguera, Rosa ^a   Machado, Isidro ^a   Piqueras, Marta ^a   Lopez Guerrero, Jose Antonio ^b   Navarro, Samuel ^a   Mayordomo, Empar ^a   Pellin, Antonio ^a   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48949118147     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-S1-S27     Document Type: Conference Paper

References (26)

1. Microarrays as validation strategies in clinical samples: tissue and protein microarrays. A Aguilar-Mahecha S Hassan C Ferrario M Basik, Omics 2006 10 311 326 10.1089/omi.2006.10.311 17069510
2. Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. LA Brown D Huntsman, J Mol Histol 2007 38 151 157 10.1007/s10735-006-9069-y 17216303
3. Tissue microarrays in clinical urology - Technical considerations. MW Kramer AS Merseburger J Hennenlotter M Kuczyk, Scand J Urol Nephrol 2007 1 7
4. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. AS Merseburger MA Kuczyk J Serth C Bokemeyer DY Young L Sun, Oncol Rep 2003 10 223 228 12469173
5. The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. RR Tubbs J Pettay TS Barry E Swain M Loftus JR Cook, J Mol Histol 2007 38 159 165 10.1007/s10735-006-9066-1 17094016
6. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. RS Bridge V Rajaram LP Dehner JD Pfeifer A Perry, Mod Pathol 2006 19 1 8 10.1038/modpathol.3800486 16258512
7. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. AL Folpe CE Hill DM Parham PA O'Shea SW Weiss, Am J Surg Pathol 2000 24 1657 1662 10.1097/00000478-200012000-00010 11117787
8. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies. M Lipinski K Braham I Philip J Wiels T Philip K Dellagi, J Cell Biochem 1986 31 289 296 10.1002/jcb.240310406 3760036
9. Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. A Llombart-Bosch S Navarro, Appl Immunohistochem Mol Morphol 2001 9 255 260 10.1097/00022744-200109000-00010 11556754
10. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. JA Lopez-Guerrero A Pellin R Noguera C Carda A Llombart-Bosch, Lab Invest 2001 81 803 814 11406642
11. Re: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. N Coleman I Roberts, Cancer Genet Cytogenet 2004 148 86 10.1016/S0165-4608(03)00209-7 14697648
12. Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. A Martinez-Ramirez S Rodriguez-Perales B Melendez B Martinez-Delgado M Urioste JC Cigudosa J Benitez, Cancer Genet Cytogenet 2003 141 138 142 10.1016/S0165-4608(02)00670-2 12606131
13. Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants. MM Subramaniam S Navarro A Pellin JA Lopez-Guerrero C Carda JA Heredia Alvaro, Virchows Arch 2006 449 435 447 10.1007/s00428-006-0271-9 16957934
14. Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas. MM Subramaniam R Noguera M Piqueras S Navarro C Carda A Pellin, Cancer Genet Cytogenet 2007 172 23 28 10.1016/j.cancergencyto.2006.07.008 17175375
15. Tissue microarrays: emerging standard for biomarker validation. S Hassan C Ferrario A Mamo M Basik, Curr Opin Biotechnol 2007 18053705
16. Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. AN Milne R Sitarz R Carvalho MM Polak M Ligtenberg P Pauwels, Hum Pathol 2007 38 903 913 10.1016/j.humpath.2006.12.010 17376510
17. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. TA Damron WG Ward A Stewart, Clin Orthop Relat Res 2007 459 40 47 10.1097/BLO.0b013e318059b8c9 17414166
18. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. K Szuhai M Ijszenga HJ Tanke C Rosenberg PC Hogendoorn, Cancer Genet Cytogenet 2006 166 173 179 10.1016/j.cancergencyto.2005.11.006 16631476
19. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. K Szuhai IJ M HJ Tanke AH Taminiau A de Schepper SG van Duinen, Cancer Genet Cytogenet 2007 172 12 22 10.1016/j.cancergencyto.2006.07.007 17175374
20. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. L Dauphinot C De Oliveira T Melot N Sevenet V Thomas BE Weissman O Delattre, Oncogene 2001 20 3258 3265 10.1038/sj.onc.1204437 11423975
21. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. R Hamelin JF Flejou F Muzeau F Potet P Laurent-Puig F Fekete G Thomas, Gastroenterology 1994 107 1012 1018 7523212
22. p53 mutations in human tumors with chimeric EWS/FLI-1 genes. R Hamelin J Zucman T Melot O Delattre G Thomas, Int J Cancer 1994 57 336 340 10.1002/ijc.2910570308 8168993
23. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. HY Huang PB Illei Z Zhao M Mazumdar AG Huvos JH Healey, J Clin Oncol 2005 23 548 558 10.1200/JCO.2005.02.081 15659501
24. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. H Kovar A Auinger G Jug D Aryee A Zoubek M Salzer-Kuntschik H Gadner, Oncogene 1993 8 2683 2690 8378080
25. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. H Kovar G Jug DN Aryee A Zoubek P Ambros B Gruber, Oncogene 1997 15 2225 2232 10.1038/sj.onc.1201397 9393981
26. Response of Ewing tumor cells to forced and activated p53 expression. H Kovar S Pospisilova G Jug D Printz H Gadner, Oncogene 2003 22 3193 3204 10.1038/sj.onc.1206391 12761489